chr17-63929430-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000626.4(CD79B):c.591+4A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000626.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD79B | NM_000626.4 | c.591+4A>T | splice_region_variant, intron_variant | ENST00000006750.8 | NP_000617.1 | |||
CD79B | NM_001039933.3 | c.594+4A>T | splice_region_variant, intron_variant | NP_001035022.1 | ||||
CD79B | NM_001329050.2 | c.282+4A>T | splice_region_variant, intron_variant | NP_001315979.1 | ||||
CD79B | NM_021602.4 | c.279+4A>T | splice_region_variant, intron_variant | NP_067613.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD79B | ENST00000006750.8 | c.591+4A>T | splice_region_variant, intron_variant | 1 | NM_000626.4 | ENSP00000006750.4 | ||||
ENSG00000285947 | ENST00000647774.1 | c.210+4A>T | splice_region_variant, intron_variant | ENSP00000497443.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Agammaglobulinemia 6, autosomal recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 10, 2022 | Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with CD79B-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 5 of the CD79B gene. It does not directly change the encoded amino acid sequence of the CD79B protein. It affects a nucleotide within the consensus splice site. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.